Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Streptococcal preparation OK-432 augments cytotoxic activity against an erythroleukemic cell line in humans

  • 13 Accesses

  • 21 Citations

Summary

The effects of OK-432, an inactivated and lyophilized preparation of a low-virulence strain of Streptococcus pyogenes, were evaluated on the cytotoxicity of lymphoid cells against a natural killer (NK)-sensitive erythroleukemic cell line K562 in patients with malignant diseases. When ten patients were treated postoperatively with daily injections of OK-432, a significant degree of augmentation in the cytotoxicity of peripheral blood lymphoid cells was evoked in all the patients, and the maximum level of cytotoxicity was on the third day after the beginning of the treatment. In spite of the successive daily administration, the level of cytotoxicity declined thereafter, but stayed higher than the pretreatment level. When OK-432 was injected IP in three patients with carcinomatous peritonitis, the cytotoxic activity of ascitic lymphoid cells was significantly enhanced. Cytotoxicity of in vitro-cultured lymphoid cells taken from peripheral blood of normal donors was also augmented by the addition of OK-432.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Djeu J, Heinbaugh JA, Holden HT, Herberman RB (1979) Augmentation of mouse natural killer cell activity by interferon and interferon inducers. J Immunol 122:175

  2. 2.

    Gidlund M, Örn A, Wigzell H, Senik A, Gresser I (1978) Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature 273:759

  3. 3.

    Hansson M, Bakacs KKT, Kiessling R, Klein G (1978) Intra-and interspecies reactivity of human and mouse natural killer (NK) cells. J Immunol 121:6

  4. 4.

    Huddlestone JR, Merigan TC Jr, Oldstone MBA (1979) Induction and kinetics of natural killer cells in humans following interferon therapy. Nature 282:417

  5. 5.

    Ishii Y, Yamaoka H, Toh K, Kikuchi K (1976) Inhibition of tumour growth in vivo and in vitro by macrophages from rats treated with a streptococcal preparation, OK-432. Gann 67:115

  6. 6.

    Japanese Research Society for Gastric Cancer (1979) The general rules for the gastric cancer study in surgery and pathology. Kanehara Press, Tokyo

  7. 7.

    Kimura I, Ohnoshi T, Yasuhara S, Sugiyama M, Urabe Y, Fujii M, Machida K (1976) Immunochemotherapy in human lung cancer using the streptococcal agent OK-432. Cancer 37:2201

  8. 8.

    Livnat S, Seigneuret M, Storb R, Prentice RL (1980) Analysis of cytotoxic effector cell function in patients with leukemia or a plastic anemia before and after marrow transplantation. J Immunol 124:481

  9. 9.

    Lozzio CB, Lozzio BB (1975) Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood 45:321

  10. 10.

    Matsubara S, Suzuki F, Ishida N (1979) Induction of immune interferon in mice treated with a bacterial immunopotentiator, OK-432. Cancer Immunol Immunother 6:41

  11. 11.

    Nauts H, Fowler GA, Bogatko FH (1953) A review of the influence of bacterial infection and bacterial products (Coley's toxins) on malignant tumours in man. Acta Med Scand [Suppl] 145:1

  12. 12.

    Okamoto H, Shoin S, Koshimura S, Shimizu R (1967) Studies on the anticancer and streptolysin S-forming abilities of hemolytic streptococci. Jpn J Microbiol 11:323

  13. 13.

    Ono T, Kurata S, Wakabayashi K, Sugawara Y, Saito M, Ogawa H (1973) Inhibitory effect of a streptococcal preparation (OK-432) on the nucleic acid synthesis in tumour cells in vitro. Gann 64:59

  14. 14.

    Oshimi K, Sumiya M, Gonda N, Kano S, Takaku F, Okumura K (1979) Enhancement of natural killer cell activity by a streptococcal preparation, OK-432. Clinical Immunology 11:867 (abstract in English)

  15. 15.

    Oshimi K, Gonda N, Sumiya M, Kano S (1980) Effects of corticosteroids on natural killer cell activity in systemic lupus erythematosus. Clin Exp Immunol 40:83

  16. 16.

    Pross HF, Baines MG (1976) Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells I. The effect of malignant disease. Int J Cancer 18:593

  17. 17.

    Rosenberg EB, McCoy JL, Green SS, Donnelly FC, Siwarski DF, Levine PH, Herberman RB (1974) Destruction of human lymphoid tissue-culture cell lines by human peripheral lymphocytes in 51Cr-release cellular cytotoxicity assays. J Natl Cancer Inst 52:345

  18. 18.

    Sakurai Y, Tsukagoshi S, Satoh H, Akiba T, Suzuki S, Takagaki Y (1972) Tumour-inhibiting effect of a streptococcal preparation (NSC-B116209). Cancer Chemother Rep 56:9

  19. 19.

    Suga S, Tsunekawa H, Washino M, Makino N, Tamura Z, Goto S (1977) Treatment of gastric cancer, with special reference to the survivals of the cancer patients treated with multiple combination MFC therapy or immunochemotherapy of MFC plus OK-432 (NSC-B116209). Gastroenterol Jpn 12(2):20

  20. 20.

    Uchida A, Hoshino T (1980) Clinical studies on cell-mediated immunity in patients with malignant disease. I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsiveness in vitro. Cancer 45:476

Download references

Author information

Correspondence to Kazuo Oshimi.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Oshimi, K., Wakasugi, H., Seki, H. et al. Streptococcal preparation OK-432 augments cytotoxic activity against an erythroleukemic cell line in humans. Cancer Immunol Immunother 9, 187–191 (1980). https://doi.org/10.1007/BF00205624

Download citation

Keywords

  • Cancer Research
  • Natural Killer
  • Peritonitis
  • Maximum Level
  • Cytotoxic Activity